You are here

ALLVIVO VASCULAR, INC.

Company Information
Address
20914 BAKE PKY
LAKE FOREST, CA -
United States



Information

UEI: R2LPKTLGG785

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Antimicrobial Peptide Treatment to Combat Wound Biofilm

    Amount: $1,615,107.00

    ABSTRACT The goal of this work is to develop a treatment for non-healing and chronic wounds that will prevent wound biofilm and facilitate healing. Chronic wounds affect approximately 6.5 million pati ...

    SBIRPhase II2020Department of Health and Human Services National Institutes of Health
  2. Antimicrobial Tracheostomy Tube to Prevent Biofilm and Reduce InfectionRisks

    Amount: $1,215,526.00

    ABSTRACT The goal of this application is to develop an antimicrobial tracheostomy tube (TT) to reduce infections associated with tracheostomies and prolonged mechanical ventilation (PMV). Approximatel ...

    SBIRPhase II2019Department of Health and Human Services National Institutes of Health
  3. Antimicrobial Peptide Treatment to Combat Wound Biofilm

    Amount: $258,580.00

    ABSTRACT The long term goal of this work is to develop a treatment for chronic wounds that will prevent wound biofilm and facilitate healingChronic wounds affect approximatelymillion patients in the U ...

    SBIRPhase I2018Department of Health and Human Services National Institutes of Health
  4. Antimicrobial Endotracheal Tube to Combat Biofilm

    Amount: $274,497.00

    ABSTRACT Ventilator associated pneumonia VAP is one of the most costly and deadly nosocomial infections Over cases of VAP occur per year resulting in over deaths and a cumulative ann ...

    SBIRPhase I2016Department of Health and Human Services National Institutes of Health
  5. Stabilized Antimicrobial Peptides to Combat Multidrug-Resistant Biofilm

    Amount: $149,961.00

    Infections involving multidrug resistant organisms (MDROs) post a substantial threat to military populations. Critical barriers to progress in the treatment of wound infections are the need for therap ...

    SBIRPhase I2015Department of Defense Defense Health Agency
  6. Dual Function Catheter to Prevent Thrombus and Infection

    Amount: $2,997,913.00

    DESCRIPTION (provided by applicant): The objective of this work is to complete development of a novel antibacterial, acute hemodialysis catheter and conduct the preclinical testing required for FDA ap ...

    SBIRPhase II2011Department of Health and Human Services National Institutes of Health
  7. Peptide Based Antibacterial Coating

    Amount: $398,235.00

    DESCRIPTION (provided by applicant): The objective of this work is to develop dual function antibacterial coatings that prevent biofilm formation and thrombus. A key feature of this technology is that ...

    SBIRPhase II2007Department of Health and Human Services National Institutes of Health
  8. Peptide Based Antibacterial Coating

    Amount: $99,547.00

    DESCRIPTION (provided by applicant): The long-term objective of this SBIR Phase I project is to develop antibacterial coatings for medical devices. The use of traditional antimicrobials on devices p ...

    SBIRPhase I2005Department of Health and Human Services National Institutes of Health
  9. SBIR/STTR Phase I:Surface Modification to Direct Cell Behavior

    Amount: $97,543.00

    This Small Business Innovation Research (SBIR) Phase I project will develop a surface coating technology that will be used to create improved materials for regulating cell behavior for research, tissu ...

    SBIRPhase I2002National Science Foundation
US Flag An Official Website of the United States Government